Webinar Series

The 5 Molecular Profiles of MammaPrint + BluePrint in ER+/HER2- Early Breast Cancer

MammaPrint BluePrint illuminating tumor biology

Join us for this webinar series as Dr. William Audeh reviews each of the five MammaPrint + BluePrint genomic profile classifications and the unique answers each provides for treatment considerations in ER+/HER2- early-stage breast cancer.

Presented by:

William Audeh, MD, MS
Chief Medical Officer
Agendia

William Audeh, MD, MS Chief Medical Officer Agendia